Annual Gross Profit
N/A
31 December 2023
Summary:
Adaptimmune Therapeutics annual gross profit is not available.ADAP Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADAP Gross Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
ADAP Gross Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time |
Adaptimmune Therapeutics Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $192.68 M(-23.7%) | - | - |
| Dec 2021 | $252.48 M(-13.7%) | - | - |
| Dec 2020 | $292.64 M(+224.4%) | - | - |
| Dec 2019 | $90.22 M(-39.5%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $149.13 M(-1.5%) | - | - |
| Dec 2017 | $151.38 M(-0.1%) | - | - |
| Dec 2016 | $151.60 M(-7.1%) | - | - |
| Dec 2015 | $163.25 M(+14.9%) | - | - |
| Dec 2013 | $142.05 M | - | - |
FAQ
- What is the all time high annual gross profit for Adaptimmune Therapeutics?
What is the all time high annual gross profit for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high annual gross profit is $292.64 M